坦克结合激酶1
生物
坏死性下垂
肿瘤坏死因子α
体内
IκB激酶
免疫学
离体
癌症研究
细胞生物学
突变
程序性细胞死亡
NF-κB
激酶
炎症
遗传学
蛋白激酶A
细胞凋亡
基因
丝裂原活化蛋白激酶激酶
作者
Justin Taft,Michael Markson,Diana Legarda,Roosheel S. Patel,Mark Chan,Louise Malle,Ashley Richardson,Conor Gruber,Marta Martín-Fernández,Grazia M.S. Mancini,Jan A. M. van Laar,Philomine van Pelt,Sofija Buta,Beatrijs Wokke,Ira K. D. Sabli,Vanessa Sancho‐Shimizu,Pallavi Pimpale Chavan,Oskar Schnappauf,Raju Khubchandani,Müşerref Kasap Cüceoğlu
出处
期刊:Cell
[Cell Press]
日期:2021-08-01
卷期号:184 (17): 4447-4463.e20
被引量:118
标识
DOI:10.1016/j.cell.2021.07.026
摘要
TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26, 7, and 8 from three unrelated consanguineous families with homozygous loss-of-function mutations in TBK1. All four patients suffer from chronic and systemic autoinflammation, but not severe viral infections. We demonstrate that TBK1 loss results in hypomorphic but sufficient IFN-I induction via RIG-I/MDA5, while the system retains near intact IL-6 induction through NF-κB. Autoinflammation is driven by TNF-induced RCD as patient-derived fibroblasts experienced higher rates of necroptosis in vitro, and CC3 was elevated in peripheral blood ex vivo. Treatment with anti-TNF dampened the baseline circulating inflammatory profile and ameliorated the clinical condition in vivo. These findings highlight the plasticity of the IFN-I response and underscore a cardinal role for TBK1 in the regulation of RCD.
科研通智能强力驱动
Strongly Powered by AbleSci AI